{"id":2631,"date":"2026-10-02T14:14:46","date_gmt":"2026-10-02T12:14:46","guid":{"rendered":"https:\/\/vitalonga.gr\/corticosteroids\/sterdax\/sterdax-gia-epangelmaties-ygeias\/"},"modified":"2026-10-05T13:11:51","modified_gmt":"2026-10-05T11:11:51","slug":"for-healthcare-professionals","status":"publish","type":"page","link":"https:\/\/vitalonga.gr\/en\/corticosteroids\/sterdax\/for-healthcare-professionals\/","title":{"rendered":"Sterdax\u00ae For Healthcare Professionals"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row][vc_column preset=&#8221;mpc_preset_91&#8243; content_preset=&#8221;_mpc_preset_91&#8243;][vc_row_inner][vc_column_inner][vc_custom_heading text=&#8221;Sterdax\u00ae&#8221; font_container=&#8221;tag:h2|font_size:24|text_align:left|color:%23558131&#8243; use_theme_fonts=&#8221;yes&#8221; css=&#8221;.vc_custom_1769373169273{margin-bottom: 10px !important;}&#8221;][vc_custom_heading text=&#8221;Dexamethasone tablets 2mg&#8221; font_container=&#8221;tag:h2|font_size:14|text_align:left&#8221; use_theme_fonts=&#8221;yes&#8221; css=&#8221;.vc_custom_1791193803153{margin-bottom: 10px !important;}&#8221;][vc_custom_heading text=&#8221;BT X 1 BOTTLE(HDPE) X 30 TABS&#8221; font_container=&#8221;tag:h2|font_size:14|text_align:left&#8221; use_theme_fonts=&#8221;yes&#8221; css=&#8221;.vc_custom_1791193812797{margin-bottom: 10px !important;}&#8221;][\/vc_column_inner][vc_column_inner width=&#8221;2\/3&#8243; css=&#8221;.vc_custom_1531988352789{padding-right: 0px !important;}&#8221; offset=&#8221;vc_col-xs-4&#8243;]<div data-id=\"mpc_divider-446ac586c198bd5\" class=\"mpc-divider-wrap\"><div class=\"mpc-divider mpc-init mpc-align--left mpc-disable--left \" ><div class=\"mpc-divider__line mpc-side--left\"><span><\/span><\/div><div class=\"mpc-divider__line mpc-side--right\"><span><\/span><\/div><\/div><\/div>[\/vc_column_inner][vc_column_inner width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1531988358229{padding-left: 0px !important;}&#8221; offset=&#8221;vc_col-xs-8&#8243;]<div data-id=\"mpc_divider-556ac586c198c12\" class=\"mpc-divider-wrap\"><div class=\"mpc-divider mpc-init mpc-align--left mpc-disable--left \" ><div class=\"mpc-divider__line mpc-side--left\"><span><\/span><\/div><div class=\"mpc-divider__line mpc-side--right\"><span><\/span><\/div><\/div><\/div>[\/vc_column_inner][\/vc_row_inner][vc_empty_space height=&#8221;45px&#8221;][\/vc_column][\/vc_row][vc_row][vc_column width=&#8221;1\/3&#8243;][vc_single_image image=&#8221;2488&#8243; img_size=&#8221;&#8221; alignment=&#8221;center&#8221; onclick=&#8221;link_image&#8221; css_animation=&#8221;none&#8221; css=&#8221;&#8221;][\/vc_column][vc_column width=&#8221;2\/3&#8243;]<div id=\"mpc_accordion-846ac586c198c76\" class=\"mpc-accordion mpc-init mpc-transition \" ><ul class=\"mpc-accordion__content\"><li class=\"mpc-accordion__item \"><div class=\"mpc-accordion-item__heading mpc-transition mpc-typography--default\"><div data-id=\"mpc_icon-866ac586c198c5e\" class=\"mpc-icon mpc-init mpc-transition mpc-effect-fade mpc-icon-hover \"><div class=\"mpc-icon-wrap\"><i class=\"mpc-icon-part mpc-regular mpc-transition  eti eti_arrow_down\"><\/i><i class=\"mpc-icon-part mpc-hover mpc-transition  eti eti_arrow_down\"><\/i><\/div><\/div><h3>General Information<\/h3><\/div><div class=\"mpc-accordion-item__content mpc-container\" ><div class=\"mpc-accordion-item__wrapper mpc-typography--default\">[vc_column_text css=&#8221;&#8221;]<strong>Sterdax<\/strong><strong>\u00ae<\/strong> is a medicinal product containing as its active substance <strong>dexamethasone<\/strong>, a synthetic corticosteroid with potent anti-inflammatory and immunosuppressive action.<\/p>\n<p>Dexamethasone belongs to the class of <strong>glucocorticoids<\/strong>, substances that mimic the action of cortisol, a natural hormone produced by the adrenal glands. It acts mainly through activation of intracellular glucocorticoid receptors. It is characterised by high anti-inflammatory potency and relatively little sodium retention.[\/vc_column_text]<\/div><\/div><\/li><li class=\"mpc-accordion__item \"><div class=\"mpc-accordion-item__heading mpc-transition mpc-typography--default\"><div data-id=\"mpc_icon-866ac586c198c5e\" class=\"mpc-icon mpc-init mpc-transition mpc-effect-fade mpc-icon-hover \"><div class=\"mpc-icon-wrap\"><i class=\"mpc-icon-part mpc-regular mpc-transition  eti eti_arrow_down\"><\/i><i class=\"mpc-icon-part mpc-hover mpc-transition  eti eti_arrow_down\"><\/i><\/div><\/div><h3>Indications<\/h3><\/div><div class=\"mpc-accordion-item__content mpc-container\" ><div class=\"mpc-accordion-item__wrapper mpc-typography--default\">[vc_column_text css=&#8221;&#8221;]Dexamethasone is a corticosteroid. It is intended for use in some endocrine and non-endocrine disorders, in some cases of cerebral oedema and for diagnostic testing of adrenocortical hyperfunction.<\/p>\n<p>STERDAX tablets are indicated for the treatment of coronavirus disease 2019 (COVID-19) in adult and adolescent patients (aged 12 years and older with body weight of at least 40 kg) who require supplemental oxygen therapy.<\/p>\n<p>Endocrine disorders: Exophthalmos of endocrine origin.<\/p>\n<p>Diagnostic purposes: The newer synthetic derivatives (dexamethasone) are used. The low-dose dexamethasone suppression test is useful for the diagnosis of Cushing\u2019s syndrome and for clarifying the underlying cause.<\/p>\n<p>Non-endocrine disorders: Dexamethasone may be used in the treatment of non-endocrine conditions responsive to corticosteroids, including:<\/p>\n<p>Allergy and anaphylaxis: Anaphylaxis.<\/p>\n<p>Arteritis, collagenosis: Polymyalgia rheumatica, polyarteritis nodosa.<\/p>\n<p>Haematological disorders: Haemolytic anaemia (also autoimmune), leukaemia, myeloma, idiopathic thrombocytopenic purpura in adults, reticulolymphoproliferative disorders (see also the section on oncological disorders).<\/p>\n<p>Gastrointestinal disorders: For treatment during the acute phase of the following: ulcerative colitis (rectal type only), regional enteritis (Crohn\u2019s disease), some forms of hepatitis.<\/p>\n<p>Muscular disorders: Polymyositis.<\/p>\n<p>Neurological disorders: Raised intracranial pressure secondary to brain tumours, acute exacerbations of multiple sclerosis.<\/p>\n<p>Ophthalmological disorders: Anterior and posterior uveitis, optic neuritis, chorioretinitis, iridocyclitis, temporal arteritis, orbital pseudotumour.<\/p>\n<p>Renal disorders: Nephrotic syndrome.<\/p>\n<p>Pulmonary disorders: Chronic bronchial asthma, aspiration pneumonitis, chronic obstructive pulmonary disease (COPD), sarcoidosis, allergic lung disease such as farmer\u2019s lung and pigeon breeder\u2019s lung, L\u00f6ffler\u2019s syndrome, cryptogenic fibrosing alveolitis.<\/p>\n<p>Rheumatic disorders: Some cases or special forms (Felty\u2019s syndrome, Sj\u00f6gren\u2019s syndrome) of rheumatoid arthritis, including juvenile rheumatoid arthritis, acute rheumatism, systemic lupus erythematosus, temporal arteritis (polymyalgia rheumatica).<\/p>\n<p>Skin disorders: Pemphigus vulgaris, bullous pemphigus, erythrodermas, severe forms of erythema multiforme (Stevens-Johnson syndrome), mycosis fungoides, dermatitis herpetiformis bullosa.<\/p>\n<p>Infections: Tuberculous meningitis with a high protein level in the cerebrospinal fluid, septic shock from Gram-negative bacteria.<\/p>\n<p>Oncological disorders: Lymphatic leukaemia, particularly of the acute form, malignant lymphoma (Hodgkin\u2019s disease, Non-Hodgkin lymphoma), metastatic breast cancer, hypercalcaemia as a result of bone metastasis or Kahler\u2019s disease.<\/p>\n<p>Miscellaneous: Severe allergic reactions, as an immunosuppressant in organ transplantation, as an adjunct in the prevention of nausea and vomiting and in the treatment of cancer with oncolytic agents that have a severe emetic effect.[\/vc_column_text]<\/div><\/div><\/li><li class=\"mpc-accordion__item \"><div class=\"mpc-accordion-item__heading mpc-transition mpc-typography--default\"><div data-id=\"mpc_icon-866ac586c198c5e\" class=\"mpc-icon mpc-init mpc-transition mpc-effect-fade mpc-icon-hover \"><div class=\"mpc-icon-wrap\"><i class=\"mpc-icon-part mpc-regular mpc-transition  eti eti_arrow_down\"><\/i><i class=\"mpc-icon-part mpc-hover mpc-transition  eti eti_arrow_down\"><\/i><\/div><\/div><h3>Posology and Method of Administration<\/h3><\/div><div class=\"mpc-accordion-item__content mpc-container\" ><div class=\"mpc-accordion-item__wrapper mpc-typography--default\">[vc_column_text css=&#8221;&#8221;]<u>Dosage <\/u><\/p>\n<p><em>Adults <\/em><\/p>\n<p>General considerations:<\/p>\n<p>The dose must be titrated based on the individual response of each person and the nature of the disease. In order to minimise adverse reactions, the lowest possible effective dose should be used (see \u201cAdverse reactions\u201d).<\/p>\n<p>The initial dose ranges from 0.5-10 mg per day depending on the disease being treated. In more severe diseases, doses greater than 10 mg may be required. The initial dose should be maintained or adjusted until the patient\u2019s response is satisfactory. Both the evening dose, which is useful for relieving morning stiffness, and the divided-dose regimen are associated with greater suppression of the \u201chypothalamic-pituitary-adrenal\u201d axis. If there is no satisfactory clinical response within a reasonable period of time, discontinue treatment with dexamethasone and give the patient other treatment.<\/p>\n<p>If the initial response is satisfactory, the maintenance dose should be determined by gradually reducing the dose to the lowest required to maintain an adequate clinical response. Chronic dosing should preferably not exceed 2 mg of dexamethasone daily.<\/p>\n<p>Patients should be monitored for any signs requiring dose adjustment. These may be changes in clinical condition as a result of relapses or exacerbations of the disease, individual response to the medicine and the effect of stress (e.g. surgery, infection, trauma). During stressful situations, a temporary increase in dose may be necessary.<\/p>\n<p>If the medicine must be stopped after more than a few days of treatment, discontinuation should be gradual.<\/p>\n<p>The following equivalences facilitate the transition to dexamethasone from other glucocorticoids:<\/p>\n<p>Comparing quantities milligram for milligram (mg), dexamethasone is approximately equivalent to betamethasone, 4 to 6 times more potent than methylprednisolone and triamcinolone, 6 to 8 times more potent than prednisone and prednisolone, 25 to 30 times more potent than hydrocortisone and approximately 35 times more potent than cortisone.<\/p>\n<p><em><u>Acute, self-limiting allergic disorders or acute exacerbations of chronic allergic disorders <\/u><\/em><\/p>\n<p>The following dosage regimen is suggested, combining parenteral and oral treatment:<\/p>\n<table>\n<tbody>\n<tr>\n<td width=\"112\">Day 1:<\/td>\n<td width=\"393\">Intramuscular injection of Dexamethasone, 4\u00a0mg or 8\u00a0mg<\/td>\n<\/tr>\n<tr>\n<td width=\"112\">Day 2:<\/td>\n<td width=\"393\">Two dexamethasone 0.5\u00a0mg tablets twice a day<\/td>\n<\/tr>\n<tr>\n<td width=\"112\">Day 3:<\/td>\n<td width=\"393\">Two dexamethasone 0.5\u00a0mg tablets twice a day<\/td>\n<\/tr>\n<tr>\n<td width=\"112\">Day 4:<\/td>\n<td width=\"393\">One dexamethasone 0.5\u00a0mg tablet twice a day<\/td>\n<\/tr>\n<tr>\n<td width=\"112\">Day 5:<\/td>\n<td width=\"393\">One dexamethasone 0.5\u00a0mg tablet twice a day<\/td>\n<\/tr>\n<tr>\n<td width=\"112\">Day 6:<\/td>\n<td width=\"393\">One dexamethasone 0.5 mg tablet<\/td>\n<\/tr>\n<tr>\n<td width=\"112\">Day 7:<\/td>\n<td width=\"393\">One dexamethasone 0.5 mg tablet<\/td>\n<\/tr>\n<tr>\n<td width=\"112\">Day 8:<\/td>\n<td width=\"393\">Reassessment<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<p>This schedule is designed to ensure adequate treatment during acute episodes while minimising the risk of overdose in chronic cases.<\/p>\n<p><u>Raised intracranial pressure: <\/u><\/p>\n<p>Initial treatment is usually by injection. When maintenance treatment is required, this should be changed to dexamethasone tablets as soon as possible. For the palliative management of patients with recurrent or inoperable brain tumours, the maintenance dose must be calculated individually for each person. A dose of 2 mg two or three times a day may be effective. The smallest dose necessary to control symptoms should always be used.<\/p>\n<p><u>Dexamethasone suppression tests: <\/u><\/p>\n<p>Tests for Cushing\u2019s syndrome:<\/p>\n<p>2 mg (1 tablet) of <strong>Sterdax<\/strong><strong>\u00ae<\/strong> should be given at 11 p.m. Blood samples are then taken at 8 a.m. the next morning for determination of plasma cortisol. For determination of 17-hydroxycorticosteroid excretion, a 24-hour urine collection should be used.<\/p>\n<p>If greater accuracy is required, 500 micrograms (1 tablet) of <strong>Sterdax<\/strong><strong>\u00ae<\/strong> should be given every 6 hours for 48 hours. Blood should be taken at 8 a.m. on the third morning for determination of plasma cortisol.<\/p>\n<p>Test to distinguish Cushing\u2019s syndrome caused by excess pituitary ACTH from the syndrome caused by other causes:<\/p>\n<p>2 mg (1 tablet) of <strong>Sterdax<\/strong><strong>\u00ae<\/strong> should be given every 6 hours for 48 hours. Blood should be taken at 8 a.m. on the third morning for determination of plasma cortisol. For determination of 17-hydroxycorticosteroid excretion, a 24-hour urine collection should be used.<\/p>\n<p>For the treatment of Covid-19 disease:<\/p>\n<p>In adult patients 6 mg orally, once a day for up to 10 days.[\/vc_column_text]<\/div><\/div><\/li><li class=\"mpc-accordion__item \"><div class=\"mpc-accordion-item__heading mpc-transition mpc-typography--default\"><div data-id=\"mpc_icon-866ac586c198c5e\" class=\"mpc-icon mpc-init mpc-transition mpc-effect-fade mpc-icon-hover \"><div class=\"mpc-icon-wrap\"><i class=\"mpc-icon-part mpc-regular mpc-transition  eti eti_arrow_down\"><\/i><i class=\"mpc-icon-part mpc-hover mpc-transition  eti eti_arrow_down\"><\/i><\/div><\/div><h3>Adverse Reactions<\/h3><\/div><div class=\"mpc-accordion-item__content mpc-container\" ><div class=\"mpc-accordion-item__wrapper mpc-typography--default\">[vc_column_text css=&#8221;&#8221;]The frequency of the expected adverse reactions, such as suppression of the \u201chypothalamic-pituitary-adrenal\u201d axis, is related to the relative potency of the active substance, the dose, the time of administration and the duration of treatment. During short-term treatment that follows the dosage recommendations and with regular monitoring of patients, the<\/p>\n<p>risk of adverse reactions is small. The following adverse reactions have been reported with the following frequency:<\/p>\n<table>\n<tbody>\n<tr>\n<td width=\"182\"><strong>System\/organ class<\/strong><\/td>\n<td width=\"137\"><strong>Frequency<\/strong><\/td>\n<td width=\"241\"><strong>Adverse reactions<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"182\">Infections and infestations<\/td>\n<td width=\"137\">Not known<\/td>\n<td width=\"241\">Increased susceptibility to infections or exacerbation of (latent) infections with suppression of clinical symptoms, opportunistic infections, reactivation of latent tuberculosis, exacerbation of eye infections, candidiasis.<\/td>\n<\/tr>\n<tr>\n<td width=\"182\">Blood and lymphatic system disorders<\/td>\n<td width=\"137\">Not known<\/td>\n<td width=\"241\">Leukocytosis, lymphopenia, eosinopenia, polycythaemia.<\/td>\n<\/tr>\n<tr>\n<td width=\"182\">Immune system disorders<\/td>\n<td width=\"137\">Not known<\/td>\n<td width=\"241\">Hypersensitivity reactions including anaphylaxis, immunosuppression (see also \u201cInfections and infestations\u201d).<\/td>\n<\/tr>\n<tr>\n<td width=\"182\">Endocrine disorders<\/td>\n<td width=\"137\">Not known<\/td>\n<td width=\"241\">Suppression of the \u201chypothalamic-pituitary-adrenal\u201d axis and induction of Cushing\u2019s syndrome (typical symptoms: moon face, erythraemia, truncal obesity), secondary adrenocortical and pituitary insufficiency (particularly in stressful situations, such as trauma or surgery).<\/td>\n<\/tr>\n<tr>\n<td width=\"182\">Metabolism and nutrition disorders<\/td>\n<td width=\"137\">Not known<\/td>\n<td width=\"241\">Weight gain, negative protein and calcium balance, increased appetite, sodium and fluid retention, potassium loss (caution: rhythm disturbances), hypokalaemic alkalosis, manifestation of latent diabetes mellitus, decreased carbohydrate tolerance with increased requirement for antidiabetic treatment, hypercholesterolaemia, hypertriglyceridaemia.<\/td>\n<\/tr>\n<tr>\n<td width=\"182\">Psychiatric disorders<\/td>\n<td width=\"137\">Not known<\/td>\n<td width=\"241\">Psychological dependence, depression, insomnia, aggravation of schizophrenia, mental disorders ranging from euphoria to the manifestation of psychosis.<\/td>\n<\/tr>\n<tr>\n<td width=\"182\">Nervous system disorders<\/td>\n<td width=\"137\">Not known<\/td>\n<td width=\"241\">Increased intracranial pressure with papilloedema in children (cerebral pseudotumour \u2013 Pseudotumor cerebri) usually after discontinuation of treatment, manifestation of latent epilepsy, increased seizures in epilepsy.<\/td>\n<\/tr>\n<tr>\n<td width=\"182\">Eye disorders<\/td>\n<td width=\"137\">Not known<\/td>\n<td width=\"241\">Increased intraocular pressure, glaucoma, papilloedema, cataract mainly with posterior subcapsular opacity, atrophy of the cornea and sclera, increased ocular viral, fungal and bacterial infections, worsening of symptoms associated with corneal ulcers, chorioretinopathy, blurred vision.<\/td>\n<\/tr>\n<tr>\n<td width=\"182\">Cardiac disorders<\/td>\n<td width=\"137\">Not known<\/td>\n<td width=\"241\">Rupture of the heart muscle following a recent history of myocardial infarction, congestive heart failure in predisposed patients.<\/td>\n<\/tr>\n<tr>\n<td width=\"182\">Vascular disorders<\/td>\n<td width=\"137\">Not known<\/td>\n<td width=\"241\">Hypertension, vasculitis, increased atherosclerosis and risk of thrombosis\/thromboembolism.<\/td>\n<\/tr>\n<tr>\n<td width=\"182\">Respiratory, thoracic and mediastinal disorders<\/td>\n<td width=\"137\">Not known<\/td>\n<td width=\"241\">Hiccups<\/td>\n<\/tr>\n<tr>\n<td width=\"182\">Gastrointestinal disorders<\/td>\n<td width=\"137\">Not known<\/td>\n<td width=\"241\">Dyspepsia, gastric ulcer with perforation and haemorrhage, acute pancreatitis, ulcerative oesophagitis, flatulence, nausea, vomiting.<\/td>\n<\/tr>\n<tr>\n<td width=\"182\">Skin and subcutaneous tissue disorders<\/td>\n<td width=\"137\">Not known<\/td>\n<td width=\"241\">Hirsutism, hypertrichosis, skin atrophy, telangiectasia, striae, erythema, steroid acne, petechiae, ecchymosis, allergic dermatitis, urticaria, angioneurotic oedema, thinning of scalp hair, pigmentation disorders, increased capillary fragility, perioral dermatitis.<\/td>\n<\/tr>\n<tr>\n<td width=\"182\">Musculoskeletal and connective tissue disorders<\/td>\n<td width=\"137\">Not known<\/td>\n<td width=\"241\">Growth inhibition in infants, children and adolescents, premature epiphyseal closure, osteoporosis, vertebral and long bone fractures, aseptic necrosis of the femoral and humeral heads, tendon rupture, proximal myopathy, muscle weakness, loss of muscle mass.<\/td>\n<\/tr>\n<tr>\n<td width=\"182\">Reproductive system and breast disorders<\/td>\n<td width=\"137\">Not known<\/td>\n<td width=\"241\">Menstrual irregularities, amenorrhoea, impotence.<\/td>\n<\/tr>\n<tr>\n<td width=\"182\">General disorders and administration site conditions<\/td>\n<td width=\"137\">Not known<\/td>\n<td width=\"241\">Delayed wound healing, malaise, steroid withdrawal syndrome: a very rapid reduction in the dose of corticosteroids after prolonged treatment may lead to acute adrenal insufficiency, hypotension and death. A &#8220;withdrawal syndrome&#8221; may occur with fever, myalgia, arthralgia, rhinitis, conjunctivitis, painful itchy skin nodules and weight loss.<\/td>\n<\/tr>\n<tr>\n<td width=\"182\">Injury, poisoning and procedural complications<\/td>\n<td width=\"137\">Not known<\/td>\n<td width=\"241\">Reduced response to vaccination and skin tests, tendency to bruise.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>[\/vc_column_text]<\/div><\/div><\/li><li class=\"mpc-accordion__item \"><div class=\"mpc-accordion-item__heading mpc-transition mpc-typography--default\"><div data-id=\"mpc_icon-866ac586c198c5e\" class=\"mpc-icon mpc-init mpc-transition mpc-effect-fade mpc-icon-hover \"><div class=\"mpc-icon-wrap\"><i class=\"mpc-icon-part mpc-regular mpc-transition  eti eti_arrow_down\"><\/i><i class=\"mpc-icon-part mpc-hover mpc-transition  eti eti_arrow_down\"><\/i><\/div><\/div><h3>SmPC<\/h3><\/div><div class=\"mpc-accordion-item__content mpc-container\" ><div class=\"mpc-accordion-item__wrapper mpc-typography--default\">[vc_column_text css=&#8221;&#8221;]Find the full SmPC of <strong>Sterdax \u00ae <a href=\"https:\/\/vitalonga.gr\/wp-content\/uploads\/2025\/10\/STERDAX-el-spc-11.05.2023-clean-2.pdf\" target=\"_blank\" rel=\"noopener\"><u>here<\/u><\/a><\/strong>[\/vc_column_text]<\/div><\/div><\/li><li class=\"mpc-accordion__item \"><div class=\"mpc-accordion-item__heading mpc-transition mpc-typography--default\"><div data-id=\"mpc_icon-866ac586c198c5e\" class=\"mpc-icon mpc-init mpc-transition mpc-effect-fade mpc-icon-hover \"><div class=\"mpc-icon-wrap\"><i class=\"mpc-icon-part mpc-regular mpc-transition  eti eti_arrow_down\"><\/i><i class=\"mpc-icon-part mpc-hover mpc-transition  eti eti_arrow_down\"><\/i><\/div><\/div><h3>Additional Links<\/h3><\/div><div class=\"mpc-accordion-item__content mpc-container\" ><div class=\"mpc-accordion-item__wrapper mpc-typography--default\">[vc_column_text css=&#8221;&#8221;]<a href=\"https:\/\/www.esmo.org\/guidelines\/esmo-clinical-practice-guideline-multiple-myeloma\" target=\"_blank\" rel=\"noopener\"><strong>ESMO Clinical Practice Guideline: Multiple Myeloma<\/strong><\/a><\/p>\n<p><a href=\"https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/809a021b-e75c-4f9c-b002-6fb13bf1a0f5\/content\" target=\"_blank\" rel=\"noopener\"><strong>WHO Guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents<\/strong><\/a><em>\u00a0<\/em><\/p>\n<p><a href=\"https:\/\/www.who.int\/teams\/health-care-readiness\/covid-19\" target=\"_blank\" rel=\"noopener\"><strong>WHO Clinical management of COVID-19 <\/strong><\/a>[\/vc_column_text]<\/div><\/div><\/li><\/ul><\/div>[\/vc_column][\/vc_row][vc_row][vc_column][vc_empty_space][vc_column_text css=&#8221;&#8221;]<strong>Warning<\/strong>:<br \/>\nThe information above is provided for informational or educational purposes. Treatment with <strong>Sterdax\u00ae<\/strong> should be initiated, continued, and discontinued strictly and only under a doctor\u2019s supervision.<\/p>\n<p>The links provided on this website that lead to external websites of international organizations, regulatory authorities, and other entities are for informational purposes only.<\/p>\n<p>Vita Longa has no commercial, financial, or other affiliation with these organizations, unless explicitly stated. Any mention or reference to them does not imply endorsement, sponsorship, or recommendation of the views, information, or services provided on the respective websites.<\/p>\n<p>Vita Longa assumes no responsibility\u00a0 for the content, accuracy or updating of the information hosted on external websites.[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column preset=&#8221;mpc_preset_91&#8243; content_preset=&#8221;_mpc_preset_91&#8243;][vc_row_inner][vc_column_inner][vc_custom_heading text=&#8221;Sterdax\u00ae&#8221; font_container=&#8221;tag:h2|font_size:24|text_align:left|color:%23558131&#8243; use_theme_fonts=&#8221;yes&#8221; css=&#8221;.vc_custom_1769373169273{margin-bottom: 10px !important;}&#8221;][vc_custom_heading text=&#8221;Dexamethasone tablets 2mg&#8221; font_container=&#8221;tag:h2|font_size:14|text_align:left&#8221; use_theme_fonts=&#8221;yes&#8221; css=&#8221;.vc_custom_1791193803153{margin-bottom: 10px !important;}&#8221;][vc_custom_heading text=&#8221;BT X 1<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":2600,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-left-sidebar.php","meta":{"_exactmetrics_skip_tracking":false,"footnotes":""},"class_list":["post-2631","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sterdax\u00ae For Healthcare Professionals - Vita Longa<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vitalonga.gr\/en\/corticosteroids\/sterdax\/for-healthcare-professionals\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sterdax\u00ae For Healthcare Professionals - Vita Longa\" \/>\n<meta property=\"og:description\" content=\"[vc_row][vc_column preset=&#8221;mpc_preset_91&#8243; content_preset=&#8221;_mpc_preset_91&#8243;][vc_row_inner][vc_column_inner][vc_custom_heading text=&#8221;Sterdax\u00ae&#8221; font_container=&#8221;tag:h2|font_size:24|text_align:left|color:%23558131&#8243; use_theme_fonts=&#8221;yes&#8221; css=&#8221;.vc_custom_1769373169273{margin-bottom: 10px !important;}&#8221;][vc_custom_heading text=&#8221;Dexamethasone tablets 2mg&#8221; font_container=&#8221;tag:h2|font_size:14|text_align:left&#8221; use_theme_fonts=&#8221;yes&#8221; css=&#8221;.vc_custom_1791193803153{margin-bottom: 10px !important;}&#8221;][vc_custom_heading text=&#8221;BT X 1\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vitalonga.gr\/en\/corticosteroids\/sterdax\/for-healthcare-professionals\/\" \/>\n<meta property=\"og:site_name\" content=\"Vita Longa\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-05T11:11:51+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"10 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/vitalonga.gr\\\/en\\\/corticosteroids\\\/sterdax\\\/for-healthcare-professionals\\\/\",\"url\":\"https:\\\/\\\/vitalonga.gr\\\/en\\\/corticosteroids\\\/sterdax\\\/for-healthcare-professionals\\\/\",\"name\":\"Sterdax\u00ae For Healthcare Professionals - Vita Longa\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/vitalonga.gr\\\/#website\"},\"datePublished\":\"2026-10-02T12:14:46+00:00\",\"dateModified\":\"2026-10-05T11:11:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/vitalonga.gr\\\/en\\\/corticosteroids\\\/sterdax\\\/for-healthcare-professionals\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/vitalonga.gr\\\/en\\\/corticosteroids\\\/sterdax\\\/for-healthcare-professionals\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/vitalonga.gr\\\/en\\\/corticosteroids\\\/sterdax\\\/for-healthcare-professionals\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/vitalonga.gr\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Corticosteroids\",\"item\":\"https:\\\/\\\/vitalonga.gr\\\/en\\\/corticosteroids\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Sterdax\u00ae\",\"item\":\"https:\\\/\\\/vitalonga.gr\\\/en\\\/corticosteroids\\\/sterdax\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Sterdax\u00ae For Healthcare Professionals\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/vitalonga.gr\\\/#website\",\"url\":\"https:\\\/\\\/vitalonga.gr\\\/\",\"name\":\"Vita Longa\",\"description\":\"\u03a6\u03b1\u03c1\u03bc\u03b1\u03ba\u03b5\u03c5\u03c4\u03b9\u03ba\u03ac \u0395\u03af\u03b4\u03b7 &amp; \u03a0\u03c1\u03bf\u03ca\u03cc\u03bd\u03c4\u03b1\",\"publisher\":{\"@id\":\"https:\\\/\\\/vitalonga.gr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/vitalonga.gr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/vitalonga.gr\\\/#organization\",\"name\":\"Vita Longa \u0399.\u039a.\u0395.\",\"url\":\"https:\\\/\\\/vitalonga.gr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/vitalonga.gr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/vitalonga.gr\\\/wp-content\\\/uploads\\\/2018\\\/05\\\/VITA_LONGA_LOGO_FINAL.jpg\",\"contentUrl\":\"https:\\\/\\\/vitalonga.gr\\\/wp-content\\\/uploads\\\/2018\\\/05\\\/VITA_LONGA_LOGO_FINAL.jpg\",\"width\":500,\"height\":84,\"caption\":\"Vita Longa \u0399.\u039a.\u0395.\"},\"image\":{\"@id\":\"https:\\\/\\\/vitalonga.gr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sterdax\u00ae For Healthcare Professionals - Vita Longa","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vitalonga.gr\/en\/corticosteroids\/sterdax\/for-healthcare-professionals\/","og_locale":"en_US","og_type":"article","og_title":"Sterdax\u00ae For Healthcare Professionals - Vita Longa","og_description":"[vc_row][vc_column preset=&#8221;mpc_preset_91&#8243; content_preset=&#8221;_mpc_preset_91&#8243;][vc_row_inner][vc_column_inner][vc_custom_heading text=&#8221;Sterdax\u00ae&#8221; font_container=&#8221;tag:h2|font_size:24|text_align:left|color:%23558131&#8243; use_theme_fonts=&#8221;yes&#8221; css=&#8221;.vc_custom_1769373169273{margin-bottom: 10px !important;}&#8221;][vc_custom_heading text=&#8221;Dexamethasone tablets 2mg&#8221; font_container=&#8221;tag:h2|font_size:14|text_align:left&#8221; use_theme_fonts=&#8221;yes&#8221; css=&#8221;.vc_custom_1791193803153{margin-bottom: 10px !important;}&#8221;][vc_custom_heading text=&#8221;BT X 1","og_url":"https:\/\/vitalonga.gr\/en\/corticosteroids\/sterdax\/for-healthcare-professionals\/","og_site_name":"Vita Longa","article_modified_time":"2026-10-05T11:11:51+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"10 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/vitalonga.gr\/en\/corticosteroids\/sterdax\/for-healthcare-professionals\/","url":"https:\/\/vitalonga.gr\/en\/corticosteroids\/sterdax\/for-healthcare-professionals\/","name":"Sterdax\u00ae For Healthcare Professionals - Vita Longa","isPartOf":{"@id":"https:\/\/vitalonga.gr\/#website"},"datePublished":"2026-10-02T12:14:46+00:00","dateModified":"2026-10-05T11:11:51+00:00","breadcrumb":{"@id":"https:\/\/vitalonga.gr\/en\/corticosteroids\/sterdax\/for-healthcare-professionals\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vitalonga.gr\/en\/corticosteroids\/sterdax\/for-healthcare-professionals\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/vitalonga.gr\/en\/corticosteroids\/sterdax\/for-healthcare-professionals\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/vitalonga.gr\/en\/"},{"@type":"ListItem","position":2,"name":"Corticosteroids","item":"https:\/\/vitalonga.gr\/en\/corticosteroids\/"},{"@type":"ListItem","position":3,"name":"Sterdax\u00ae","item":"https:\/\/vitalonga.gr\/en\/corticosteroids\/sterdax\/"},{"@type":"ListItem","position":4,"name":"Sterdax\u00ae For Healthcare Professionals"}]},{"@type":"WebSite","@id":"https:\/\/vitalonga.gr\/#website","url":"https:\/\/vitalonga.gr\/","name":"Vita Longa","description":"\u03a6\u03b1\u03c1\u03bc\u03b1\u03ba\u03b5\u03c5\u03c4\u03b9\u03ba\u03ac \u0395\u03af\u03b4\u03b7 &amp; \u03a0\u03c1\u03bf\u03ca\u03cc\u03bd\u03c4\u03b1","publisher":{"@id":"https:\/\/vitalonga.gr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vitalonga.gr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/vitalonga.gr\/#organization","name":"Vita Longa \u0399.\u039a.\u0395.","url":"https:\/\/vitalonga.gr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/vitalonga.gr\/#\/schema\/logo\/image\/","url":"https:\/\/vitalonga.gr\/wp-content\/uploads\/2018\/05\/VITA_LONGA_LOGO_FINAL.jpg","contentUrl":"https:\/\/vitalonga.gr\/wp-content\/uploads\/2018\/05\/VITA_LONGA_LOGO_FINAL.jpg","width":500,"height":84,"caption":"Vita Longa \u0399.\u039a.\u0395."},"image":{"@id":"https:\/\/vitalonga.gr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/vitalonga.gr\/en\/wp-json\/wp\/v2\/pages\/2631","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vitalonga.gr\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/vitalonga.gr\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/vitalonga.gr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/vitalonga.gr\/en\/wp-json\/wp\/v2\/comments?post=2631"}],"version-history":[{"count":4,"href":"https:\/\/vitalonga.gr\/en\/wp-json\/wp\/v2\/pages\/2631\/revisions"}],"predecessor-version":[{"id":2746,"href":"https:\/\/vitalonga.gr\/en\/wp-json\/wp\/v2\/pages\/2631\/revisions\/2746"}],"up":[{"embeddable":true,"href":"https:\/\/vitalonga.gr\/en\/wp-json\/wp\/v2\/pages\/2600"}],"wp:attachment":[{"href":"https:\/\/vitalonga.gr\/en\/wp-json\/wp\/v2\/media?parent=2631"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}